Insider Transactions in Q4 2021 at Ikena Oncology, Inc. (IKNA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,959
-0.48%
|
$83,426
$14.0 P/Share
|
|
Dec 14
2021
|
Jean Francois Formela |
SELL
Open market or private sale
|
Indirect |
5,959
-0.48%
|
$83,426
$14.0 P/Share
|
|
Dec 13
2021
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,330
-0.66%
|
$116,620
$14.64 P/Share
|
|
Dec 13
2021
|
Jean Francois Formela |
SELL
Open market or private sale
|
Indirect |
8,330
-0.66%
|
$116,620
$14.64 P/Share
|
|
Dec 10
2021
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-2.2%
|
$14,000
$14.76 P/Share
|
|
Dec 10
2021
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.15%
|
$2,000
$2.15 P/Share
|
|
Dec 10
2021
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,989
-0.95%
|
$179,835
$15.03 P/Share
|
|
Dec 10
2021
|
Jean Francois Formela |
SELL
Open market or private sale
|
Indirect |
11,989
-0.95%
|
$179,835
$15.03 P/Share
|